Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Anxo Pharmaceutical Co., Ltd. (6677:TWSE), powered by AI.
Anxo Pharmaceutical Co., Ltd. is currently trading at $16.85. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Anxo Pharmaceutical Co., Ltd. on Alpha Lenz.
View Anxo Pharmaceutical Co., Ltd.'s valuation metrics on Alpha Lenz.
“Anxo Pharmaceutical Co., Ltd.'s ROE is -3.4%. Explore profitability and growth together.”
Ask for details →Anxo Pharmaceutical Co., Ltd. is a specialty pharmaceutical company based in Taipei, Taiwan, established in 2003. The company develops, manufactures, and markets a diverse array of pharmaceutical products, catering to both medical professionals and patients domestically and internationally. Its product portfolio covers both prescription and over-the-counter medications, encompassing major therapeutic areas such as cardiovascular care, metabolic disorders, central nervous system diseases, diabetes, respiratory illnesses, anti-infective treatments, dermatology, nephrology, urology, and orthopedics. Anxo is recognized for offering a comprehensive range of pharmaceutical formulations, including oral drugs, injectables, and topical preparations, addressing a broad spectrum of therapeutic needs. The company also supports the pharmaceutical sector with analytical method development and validation services. As an active participant in Taiwan’s healthcare sector, Anxo Pharmaceutical plays a significant role in supplying essential medicines across various specialties, contributing to the accessibility and advancement of medical treatment options in the region.
“Anxo Pharmaceutical Co., Ltd.'s ROE is -3.4%. Explore profitability and growth together.”
Ask for details →Anxo Pharmaceutical Co., Ltd. (ticker: 6677) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
The current price is 16.85 with a P/E ratio of -x and P/B of -x.
ROE is -3.39% and operating margin is -5.09%. Annual revenue is $843M.